Loxo Oncology (LOXO) Tops Q1 EPS by 10c

Loxo Oncology (NASDAQ: LOXO) reported Q1 EPS of ($0.59), $0.10 better than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.

You May Also Be Interested In

• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Paramount Global (PARA) Tops Q2 EPS by 480c
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c